Sheaff Brock Investment Advisors, LLC Halozyme Therapeutics, Inc. Transaction History
Sheaff Brock Investment Advisors, LLC
- $1.08 Billion
- Q1 2025
A detailed history of Sheaff Brock Investment Advisors, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Sheaff Brock Investment Advisors, LLC holds 7,869 shares of HALO stock, worth $523,052. This represents 0.05% of its overall portfolio holdings.
Number of Shares
7,869
Previous 7,747
1.57%
Holding current value
$523,052
Previous $370,000
35.68%
% of portfolio
0.05%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding HALO
# of Institutions
629Shares Held
127MCall Options Held
408KPut Options Held
384K-
Black Rock Inc. New York, NY17.6MShares$1.17 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$814 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$395 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$230 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$226 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9.26B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...